Tumor Biology

, Volume 36, Issue 3, pp 2007–2012 | Cite as

Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer

  • Qier Li
  • Yongfu Shao
  • Xinjun Zhang
  • Tuo Zheng
  • Min Miao
  • Lijun Qin
  • Bojun Wang
  • Guoliang Ye
  • Bingxiu Xiao
  • Junming Guo
Research Article

Abstract

Long intergenic non-protein-coding RNA 152 (LINC00152) is one of the long noncoding RNAs (lncRNAs) abnormally expressed in gastric cancer tissues. However, its value in the diagnosis of gastric cancer is unclear. The aim of this study is to evaluate the clinical significance of plasma LINC00152 as a biomarker in the screening of gastric cancer and to explore the possible mechanism underling its stable existence in blood. We analyzed the levels of plasma LINC00152 in patients with gastric cancer and gastric epithelial dysplasia and healthy controls using quantitative reverse transcription polymerase chain reaction and then confirmed by sequencing. We also compared its levels in paired preoperative and postoperative plasma samples. In addition, we compared the levels of LINC00152 in plasma and in exosomes, which were extracted from the same plasma and confirmed by transmission electron microscopy. The levels of plasma LINC00152 were significantly elevated in gastric cancer patients compared with healthy controls. The sensitivity and specificity of plasma LINC00152 in the diagnosis of gastric cancer were 48.1 and 85.2 %, respectively. There were no significant differences of LINC00152 levels between gastric epithelial dysplasia patients and healthy controls. LINC00152 levels in preoperative plasma samples were lower than those in postoperative ones. There were also no differences between LINC00152 levels in plasma and in exosomes. All these results suggested that LINC00152 can be detected in plasma, and one of the possible mechanisms of its stable existence in blood was protected by exosomes. It has the possibility to be applied in gastric cancer diagnosis as a novel blood-based biomarker.

Keywords

Long noncoding RNA LINC00152 Gastric cancer Plasma Tumor marker Exosome 

Notes

Acknowledgments

This work was supported by the Zhejiang Provincial Natural Science Foundation of China (No. LY14C060003), the Applied Research Project on Nonprofit Technology of Zhejiang Province (No. 2014C33222), the National Natural Science Foundation of China (No. 81171660), the Natural Science Foundation of Ningbo (No. 2013A610206), the Scientific Innovation Team Project of Ningbo (No. 2011B82014), the Open Foundation of the Zhejiang Provincial Key Laboratory of Pathophysiology (No. 201302), the Scientific Research Project of Ningbo University (No. XYY13002), and the K. C. Wong Magna Fund in Ningbo University.

Conflict of interest

None

References

  1. 1.
    Ferlay J, Shin HR, Bray F, Forman D, Mather C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.CrossRefPubMedGoogle Scholar
  2. 2.
    Maruyama R, Suzuki H. Long noncoding RNA involvement in cancer. BMB Rep. 2012;45:604–11.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Qi P, Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol. 2013;26:155–65.CrossRefPubMedGoogle Scholar
  4. 4.
    Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J, et al. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J. 2012;279:3159–65.CrossRefPubMedGoogle Scholar
  5. 5.
    Mei D, Song H, Wang K, Lou Y, Sun W, Liu Z, et al. Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association. Med Oncol. 2013;30:709.CrossRefPubMedGoogle Scholar
  6. 6.
    Sun W, Wu Y, Yu X, Liu Y, Song H, Xia T, et al. Decreased expression of long noncoding RNA AC096655.1-002 in gastric cancer and its clinical significance. Tumour Biol. 2013;34:2697–701.CrossRefPubMedGoogle Scholar
  7. 7.
    Xiao B, Guo J. Long noncoding RNA AC096655.1-002 has been officially named as gastric cancer-associated transcript 1, GACAT1. Tumour Biol. 2013;4:3271.CrossRefGoogle Scholar
  8. 8.
    Song H, Sun W, Ye G, Ding X, Liu Z, Zhang S, et al. Long non-coding RNA expression profile in human gastric cancer and its clinical significances. J Transl Med. 2013;11:225.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Arita T, Ichikawa D, Konishi H, Komatsu S, Shiozaki A, Shoda K, et al. Circulating long non-coding RNAs in plasma of patients with gastric cancer. Anticancer Res. 2013;33:3185–93.PubMedGoogle Scholar
  10. 10.
    Tang H, Wu Z, Zhang J, Su B. Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Mol Med Rep. 2013;7:761–6.PubMedGoogle Scholar
  11. 11.
    Hessels D, Klein Gunnewiek JM, Van Oort I, Karthaus HF, van Leenders GJ, van Balken B, et al. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol. 2003;44:8–16.CrossRefPubMedGoogle Scholar
  12. 12.
    Pang Q, Ge J, Shao Y, Sun W, Song H, Xia T, et al. Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance. Tumour Biol. 2014;35:5441–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17:3077–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Orozco AF, Lewis DE. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A. 2010;77:502–14.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Record M, Subra C, Silvente-Poirot S, Poirot M. Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol. 2011;81:1171–82.CrossRefPubMedGoogle Scholar
  16. 16.
    Bagaria B, Sood S, Sharma R, Lalwani S. Comparative study of CEA and CA19-9 in esophageal, gastric and colon cancers individually and in combination (ROC curve analysis). Cancer Biol Med. 2013;10:148–57.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Ferreiral LB, Palumbo A, de Mello KD, Sternberg C, Caetano MS, de Oliveira FL, et al. PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling. BMC Cancer. 2012;12:507.CrossRefGoogle Scholar
  18. 18.
    Gutschner T, Hämmerle M, Eissmann M, Hsu J, Kim Y, Hung G, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013;73:1180–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Shao Y, Chen H, Jiang X, Chen S, Li P, Ye M, et al. Low expression of lncRNA-HMlincRNA717 in human gastric cancer and its clinical significances. Tumour Biol. 2014. doi: 10.1007/s13277-014-2243-z.Google Scholar
  20. 20.
    Xu C, Shao Y, Xia T, Yang Y, Dai J, Luo L, et al. lncRNA-AC130710 targeting by miR-129-5p is upregulated in gastric cancer and associates with poor prognosis. Tumour Biol. 2014. doi: 10.1007/s13277-014-2274-5.Google Scholar
  21. 21.
    Chen S, Li P, Xiao B, Guo J. Long noncoding RNA HMlincRNA717 and AC130710 have been officially named as gastric cancer associated transcript 2 (GACAT2) and GACAT3, respectively. Tumour Biol. 2014;35:8351–2.CrossRefPubMedGoogle Scholar
  22. 22.
    Lee GL, Dobi A, Srivastava S. Prostate cancer: diagnostic performance of the PCA3 urine test. Nat Rev Urol. 2011;8:123–4.CrossRefPubMedGoogle Scholar
  23. 23.
    Tinzl M, Marberger M, Horvath S, Chypre C. DD3PCA3 RNA analysis in urine-a new perspective for detecting prostate cancer. Eur Urol. 2004;46:182–7.CrossRefPubMedGoogle Scholar
  24. 24.
    Ren S, Wang F, Shen J, Sun Y, Xu W, Lu J, et al. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur J Cancer. 2013;49:2949–59.CrossRefPubMedGoogle Scholar
  25. 25.
    Huang X, Yuan T, Tschannen M, Sun Z, Jacob H, Du M, et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics. 2013;14:319.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Qier Li
    • 1
  • Yongfu Shao
    • 2
  • Xinjun Zhang
    • 1
  • Tuo Zheng
    • 1
  • Min Miao
    • 1
  • Lijun Qin
    • 1
  • Bojun Wang
    • 1
  • Guoliang Ye
    • 1
  • Bingxiu Xiao
    • 2
  • Junming Guo
    • 2
  1. 1.The Affiliated Hospital of Ningbo University School of MedicineNingboChina
  2. 2.Zhejiang Provincial Key Laboratory of Pathophysiology, Department of Biochemistry and Molecular BiologyNingbo University School of MedicineNingboChina

Personalised recommendations